🇺🇸 Duloxetine hydrochloride - 60 mg in United States

21 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Product Substitution Issue — 4 reports (19.05%)
  2. Drug Ineffective — 3 reports (14.29%)
  3. Anxiety — 2 reports (9.52%)
  4. Depression — 2 reports (9.52%)
  5. Fibromyalgia — 2 reports (9.52%)
  6. Pain — 2 reports (9.52%)
  7. Paraesthesia — 2 reports (9.52%)
  8. Suicidal Ideation — 2 reports (9.52%)
  9. Abnormal Behaviour — 1 report (4.76%)
  10. Abnormal Dreams — 1 report (4.76%)

Source database →

Duloxetine hydrochloride - 60 mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Duloxetine hydrochloride - 60 mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Duloxetine hydrochloride - 60 mg in United States?

Eli Lilly and Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.